Posted at the Institutional Resources for Unique Collection and Academic Archives at Tokyo Dental College,
Available from http://ir.tdc.ac.jp/
Title
Review of systematic reviews on mandibular
advancement oral appliance for obstructive sleep
apnea: The importance of long-term follow-up.
Author(s)
Alternative
Sato, K; Nakajima, T
Journal
The Japanese dental science review, 56(1): 32-37
URL
http://hdl.handle.net/10130/5099
Right
This is an open access article distributed under
the terms of the
Creative Commons CC BY license, which permits
unrestricted use,
distribution, and reproduction in any medium,
provided the original
work is properly cited.
Description
JapaneseDentalScienceReview56(2020)32–37
Contents lists available atScienceDirect
Japanese
Dental
Science
Review
j o u r n a l h o m e p a g e :w w w . e l s e v i e r . c o m / l o c a t e / j d s r
Review
Article
Review
of
systematic
reviews
on
mandibular
advancement
oral
appliance
for
obstructive
sleep
apnea:
The
importance
of
long-term
follow-up
Kazumichi
Sato
a,∗,
Tsuneya
Nakajima
baDepartmentofOralMedicine,OralandMaxillofacialSurgery,TokyoDentalCollege,Chiba,272-8513,Japan bDivisionofOtorhinolaryngology,IchikawaGeneralHospital,TokyoDentalCollege,Chiba,272-8513,Japan
a
r
t
i
c
l
e
i
n
f
o
Articlehistory: Received20May2019
Receivedinrevisedform23May2019 Accepted27October2019
Keywords: Oralappliance Obstructivesleepapnea
Mandibularadvancementoralappliance Systematicreview
Clinic-baseddentists
s
u
m
m
a
r
y
Thepurposeofthisreviewwastopresentthecurrentlyavailableinformationonoralappliance(OA) therapyfordentists,especiallyclinic-baseddentists,toaidtheminperformingthistreatmentforthe managementofsymptomsofobstructivesleepapnea(OSA).Theclinicalresearchevidencecomprised ofsystematicreviewsconcernedwiththemandibularadvancementoralappliance(OAm).Continuous positiveairwaypressure(CPAP)issuperiortoOAtherapyinimprovingOSAsymptoms.Itisnecessary tosurveytheadherenceofpatientswhostoppedCPAPtherapytoOAmtherapy.Thereislittleevidence supportingthetheorythatOAmtherapypreventscardiovasculardiseaseorimprovesprognosis.There isstillroomtoinvestigatethetypesofOAm.OAmtherapyhascleardentalandskeletalsideeffects withlong-termuse,andtheseareimportantfordentists.However,acertainpercentageofpatients discontinueconsultations.Regardingconsultationrateforfollow-upandrepair/adjustmentsofOAm, thereareadvantagesfortheclinic-baseddentiststreatingOSAwithOAm.Webelievethatenhancing under-graduateandpost-graduateeducationonsleepmedicine,andestablishingaspecialistsystem couldbethestrategiesforenablingthedentiststohandleOAmtherapyindentalclinics.
©2019TheAuthors.PublishedbyElsevierLtdonbehalfofTheJapaneseAssociationforDental Science.ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/ licenses/by-nc-nd/4.0/).
1. Introduction
Oralappliance(OA)therapyforobstructivesleepapnea(OSA) attractedattentionintheWesterncountriesintheearly1990s.In Japan,OAbecameanacceptedtreatmentoptionforOSAinthe mid-1990s,andwasintroducedintotheNationalHealthInsurancein 2004.OSAisnormallydiagnosedbydoctors.Thisisbecausemany sleepdisordersexistasadifferentialdiagnosis.Whendoctorsselect OAasthemodeoftreatment,theyrequestthedentistto fabri-catethedevice.Ifthepatientsreportwithareferralfromadoctor, theyareeligibletoreceiveOAtherapythroughtheNationalHealth Insurance.
Thedentistswhocollaboratewithspecialistsinsleepmedicine performOAtherapy.Theseareusuallydentistsworkingatgeneral hospitalsordentalhospitals.DentalstudentsinJapanalsohave receivedsufficienteducationonOAtherapyforOSA.Some text-booksonOAtherapyforOSAhavebeenpublished,andscientific
∗ Correspondingauthor.
E-mailaddress:[email protected](K.Sato).
organizationsofsleepdentalmedicinehavebeeninauguratedin manycountriesincludingJapan.Therewillnowbemore oppor-tunities for clinic-based dentists to handle OA therapy. Hence, wereviewedthecurrentlyavailableevidenceonOAtherapyand providethe information usefulfor clinic-based dentiststo per-formOAtherapy.Inparticular,wehavefocusedonanddiscussed theimportance offollow-up monitoring.Regarding thetype of OA,mandibularadvancementoralappliance(OAm)hasbeen con-sidered more mainstream. The clinical research evidence used systematicreviews(SR)onOAmforthisstudy.
2. ReviewofSRs
2.1. Searchresults
The primary database used was Medline (via PubMed). No limits were applied to the year of study, but only studies published in the English language were included. A thorough literature search was conducted, and was completed on April 11, 2019. The search strategy used: (”Sleep apnea”[TIAB] OR “Sleep apnoea” OR ¨Sleep Apnea Syndromes¨[MeSH] OR “Sleep
https://doi.org/10.1016/j.jdsr.2019.10.002
1882-7616/©2019TheAuthors.PublishedbyElsevierLtdonbehalfofTheJapaneseAssociationforDentalScience.ThisisanopenaccessarticleundertheCCBY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/).
K. Sato, T. Nakajima / Japanese Dental Science Review 56 (2020) 32–37 33
Descriptionsofincludedsystematicreviews.
Firstauthor,
year
Journal AimsofSR:evaluationitems(primary
outcomes)
Numberof
includedstudies
SummaryofConclusions
Hoekema,2004 CritRevOralBiol
Med.
EfficacyandsideeffectsofOAm 13(respectively) OAmtherapyisaviabletreatmentespeciallyformildtomoderateOSA.
Lim,2006 CochraneDatabase
SystRev.
ComparisonbetweenOAmandother
treatments(daytimesleepiness,AHI)
17 ThereisincreasingevidencesuggestingthatOAmimprovessubjectivesleepinessandsleep
disorderedbreathing.CPAPappearstobemoreeffectiveinimprovingsleepdisorderedbreathing
thanOAm.
Ahrens,2010 AmJOrthod
DentofacialOrthop.
EfficacyofdifferentOAms(thesubjective
patient-centeredoutcome)
14 ThereisnospecificOAmdesignthatmosteffectivelyinfluencesthesubjectivelyperceived
treatmentefficacy
Ahrens,2011 EurJOrthod. EfficacyofdifferentOAms
(polysomnographicindices)
14 ThereisnospecificOAmdesignthatmosteffectivelyimprovespolysomnographicindices
Alsufyani,2013 SleepBreath. Changesintheupperairwayaftertherapy 3onOAm TheavailablepublishedstudiesprovideevidenceutilizingCBCTtomeasureanatomicairway
changespostsurgicalanddentalappliancetreatmentforOSA.
Iftikhar,2013 JClinSleepMed. EfficacyofOAm(bloodpressure) 7 ThepooledestimateshowsafavorableeffectofOAmonbloodpressure.
Okuno,2014 JOralRehabil. ComparisonbetweenOAmandCPAP
(AHI,ESS,arousalindexlowestSpO2,
SF-36)
5 OAmimprovesOSAwhencomparedwithuntreatedcontrols.CPAPappearstobemoreeffectivein
improvingOSAthanOAm.
Guarda-Nardini, 2015
JClinSleepMed. Predictivemethodsfortheefficacyof
OAm
13 Themandibularplaneangleandthedistancebetweenhyoidboneandmandibularplanewerefound
tohaveapredictivevalueforOAmeffectivenessinOSApatients.
Saffer,2015 IntArch
Otorhinolaryngol.
Predictivemethodsfortheefficacyof
OAm
14 Itremainsunclearwhichpredictivefactorcanbeusedwithconfidencetoselectpatientssuitablefor
treatmentwithOAm.
Bratton,2015 LancetRespirMed. ComparisonbetweenOAmandCPAP
(ESS)[networkmeta-analysis]
13onOAm CPAPseemedtobeamoreeffectivetreatmentthanOAm,andhadanincreasinglylargereffecton
moresevereorsleepierOSApatientswhencomparedwithinactivecontrols.
Sharples,2016 SleepMedRev. ComparisonbetweenOAmandCPAP
(AHI,ESS)
22onOAm CPAPisthemostclinicallyeffectivetreatmentinreducingAHIinmoderatetosevereOSA.
Serra-Torres, 2016
Laryngoscope. EfficacyofdifferentOAms 22 Adjustableandcustom-madeOAmsgivebetterresultsthanfixedandprefabricatedappliances.
Monoblocappliancescausemoreadverseeffects.
Okuno,2016 SleepMedRev. Predictivemethodsfortheefficacyof
OAm
17 Thepredictiveaccuracyvarieddependingonthedefinitionsoftreatmentsuccessusedaswellasthe
typeofindextest.
Bartolucci,2016 SleepBreath. Efficacyofdifferentamountsof
mandibularadvancement
13 TheAHIimprovementwasnotproportionaltothemandibularadvancementincrease.
Kastoer,2016 JClinSleepMed. Efficacyofremotelycontrolled
mandibularpositioner
4 RemotelycontrolledmandibularpositionermightbeapromisinginstrumentforpredictingOAm
treatmentoutcomeandtargetingthedegreeofmandibularadvancementneeded.
Kuhn,2017 Chest. ComparisonbetweenOAmandCPAP
(SF-36)
23 CPAPiseffectiveinimprovinghealth-relatedQOLinOSA,andOAmmaybejustaseffective,but
furtherRCTscomparingthetwotreatmentsarerequired.
Iftikhar,2017 SleepMed. ComparisonbetweenOAmandother
treatments(AHI,ESS)
Total80 CPAPisthemostefficaciousincompleteresolutionofsleepapneaandinimprovingtheindicesof
saturationduringsleep.
Cammaroto, 2017
MedOralPatolOral
CirBucal.
ComparisonbetweenOAmandCPAP
(AHI,ESS,lowestSpO2)
6 CPAPstillmustbeconsideredthegoldstandardtreatmentforOSAand,therefore,OAmmaybe
includedinthelistofalternativeoptions.
Sivaramakrishnan, 2017
JIndianProsthodont
Soc.
EfficacyofdifferentOAms 5 Theresultsfromthissystematicreviewdidnotshowsignificantadvantagesinusingtitratable
appliances
Schwartz,2018 SleepBreath. ComparisonbetweenOAmandCPAP
(Sleepiness,AHI,QOL,usagecompliance)
12 ThoughCPAPissignificantlymoreefficientinreducingAHI(moderatequalityofevidence),ithasa
significantlylowercomplianceresultinginnodifferencesinQOLwithOAm,andnocognitiveor
functionaloutcomes.
deVries,2018 SleepMedRev. EfficacyofOAm(cardiovascular
outcomes)
11 ItcouldbespeculatedthatOAmmayleadtoareductioninlong-termcardiovascularmorbidityand
mortalityinOSApatients.
Gao,2018 JFormosMedAssoc. ComparisonbetweenOAmandother
minimallyinvasivetreatments(AHI,ESS)
Total89 ConsideringtheeffectivenessinreducingbothAHIandESS,CPAPwasrankedthebest,followedby
OAmandpositionaltherapy,whilelifestylemodificationalonewastheleasteffectiveintervention.
Chen,2018 JOralMaxillofac
Surg.
Changesintheupperairwayaftertherapy
(computationalfluiddynamicsanalysis)
2onAm IntheresponderstoOAmtherapy,thevelocity,wallstaticpressure,andairwayresistanceofthe
upperairwaydecreased.InnonresponderstoOAmtherapy,thewallstaticpressureandairway
resistanceoftheupperairwayincreased.
Araie,2018 SleepMedRev. SideeffectsofOAm 21 SignificantchangeofOJ,OB,andL1-MPwasobservedinpatientswithlong-termOAuse,whilethere
werenosignificantchangesofskeletalindicesormandibularrotation.
Zhang,2018 Cranio. ComparisonbetweenOAmandCPAP
(AHI,lowestSpO2)
14 EventhoughCPAPcanbetterdecreasetheseverityofOSA,morepatientsoptedforOAm,which
showedbetterresultsinseverepatients,especiallyadjustableOAm.
Martins,2018 DentalPressJ
Orthod.
SideeffectsofOAm 6 ThelimitedavailableevidencesuggeststhatOAmtherapyforsnoringandOSAresultsinchangesin
craniofacialmorphologythatarepredominantlydentalinnature,especiallyonalong-termbasis.
Bartolucci,2019 EurJOrthod. SideeffectsofOAm 6 OAmtherapyproducestime-relateddentalandskeletalsideeffects.
AHI:apneahypopneaindex,CBCT:conebeamcomputedtomography,CPAP:nasalcontinuouspositiveairwaypressure,ESS:EpworthSleepinessScale,OAm:mandibularadvancementoralappliance,OSA:obstructivesleep apnea(includingobstructivesleepapnea-hypopneasyndrome),OJ:overjet,OB:overbite,QOL:qualityoflife,RCT:randomizedcontrolledtrial.
34 K.Sato,T.Nakajima/JapaneseDentalScienceReview56(2020)32–37
apnea syndrome”[TIAB] OR “Sleep apnoea syndrome”[TIAB] OR “Sleepapnea hypopneasyndrome”[TIAB]“Sleepapnea, Obstruc-tive”[MeSH]OR“Obstructivesleepapnea”[TIAB]OR“Obstructive sleepapnoea”OR“Obstructivesleepapneasyndrome”[TIAB]OR “Obstructivesleepapnoeasyndrome”[TIAB]OR“Obstructivesleep apneahypopneasyndrome”[TIAB] OR“Sleepdisordered breath-ing”[TIAB]OR“Sleeprelatedrespiratorydisorder”[TIAB]OR“Sleep respiratorydisorder”[TIAB])AND(“Oralappliance”[TIAB]OR“Oral device”[TIAB]OR“Oralsplint”[TIAB]OR“Mandibularadvancement appliance”[TIAB] OR “Mandibular advancement device”[TIAB] OR “Mandibular advancement splint”[TIAB] OR “Dental appli-ance”[TIAB]OR“Dentaldevice”[TIAB]OR“Dentalsplint¨[TIAB]OR “Mandibularrepositioningappliance”[TIAB]OR“Mandibular repo-sitioningdevice”[TIAB]OR“Mandibularrepositioningsplint”[TIAB] OR“Prostheticmandibularadvancement”[TIAB]OR“Mandibular Advancement/instrumentation¨[MeSH])AND (( ¨Meta-Analysis¨[PT] OR ¨meta-analysis¨[TIAB])OR( ¨CochraneDatabaseSystRev¨[TA]or ¨systematicreview¨[TIAB])).Wesearchedthrough50articles,and excluded articles on pediatric subjects, treatments other than OA,andthosewritteninlanguagesotherthanEnglish.Wealso excluded the articles, such as short communications, evidence reports,andclinicalpracticeguidelines.ThereweresomeCochrane reviewsbyLimJetal.,andanSRin2006[1]wasnotsearchedin thissearchstrategy.However,weincludedthisSR.Zhuetal.[2] includedstudiesonOA,butnotOAm.Liuetal.[3]didnotdescribe thetypesofOA,andhencethoseSRswereexcluded.Ultimately,27 articleswereincluded[1,4–29].DescriptionsoftheincludedSRs areshowninTable1.In2016,Al-Jewairetal.[30]examinedthe methodologicalqualityoftheSRsandthemeta-analyses(MA)on OAtherapy.TheyconcludedthattheSRsonOAtherapyforadult andpediatricsleep-disorderedbreathing’wereconductedwithan overallacceptablemethodologicalquality.
Breakdown of the content of the 27 SRs is as follows: there were 10 articles on comparison with other treatments [1,9,12,13,18–20,22,24,27], five articles on the types of OAm [5,6,14,16,21],andsixarticlesontheeffectofOAmandthe associ-atedsideeffects[4,8,23,26,28,29].Therewerealsothreearticleson predictingthetherapeuticeffectofOAm[10,11,15],twoarticleson changesintheupperrespiratorytractcausedbythistherapy[7,25], andone articleona remotelycontrolledmandibularpositioner [17].TheSRbyOkunoetal.[15]basedonpredictingthetherapeutic effectsofOAmwasthelatest.Theyconcludedthatthepredictive accuracyvarieddependingonthedefinitionsoftreatmentsuccess used,aswellasthetypeofindextest.
2.2. Comparisonwithothertreatments
TheSRsoncomparisonofOAmwithothertreatmentsalways includednasalcontinuouspositiveairwaypressure (CPAP).OSA symptomsweresetasstudyoutcomes,andtheseincludedApnea HypopneaIndex(AHI),EpworthSleepinessScale,andQualityof Life.Cross-overstudieswerealsoincluded;andhence,therewere alargenumberofshort-termstudies.AlltheSRsstatedthatthe CPAPwasmoreeffectivethanOAmwithrespecttothe aforemen-tionedoutcomes.Cammarotoetal.[20]concludedthatCPAPstill mustbeconsideredthegoldstandardtreatmentforOSA,andOAm maybeincludedinthelistofalternativeoptions.Kuhnetal.[18] examinedtheQualityofLifeindexandcommentedthatCPAPwas effectiveinachievingthisoutcome.Theyalsocarefullycommented thatinvestigationwitharandomizedcontrolledtrial(RCT)was needed.Schwartzetal.[22]examinedadherence,and analyzed thattheusagetimeofCPAPisaroundonehourshorterthanthat ofOAm.However,theseresultsdemonstrated a highdegreeof heterogeneitybetweenstudies.
CPAP and OAm are the two major conservative treatment optionsforOSA.WealsoreachedthefinalconclusionthatCPAPis
superiortoOAmintermsofimprovingOSAsymptoms,astypified bytheAHI.Thereisstillroomtoinvestigateadherence.Itis par-ticularlyessentialtomonitortheadherenceofpatientswhohave withdrawnfromCPAPtherapy,whentheyuseOAm.Ontheother hand,inclinicalpractice,itisimportanttopursuethereasonwhy patientsareunabletouseCPAPorOAmcontinuously,and take actiontoexcludetherespectivecauses.Goodadherencecanbe achievedwithinafewmonths.
2.3. TypesofOAm
TherearevarioustypesofOAm.OAmarebroadlydividedinto twotypes:typeswithupperandlowerjawsseparatedandtypes withfixedjaws.InJapan,whenOAtherapyisprovidedthrough theNationalHealthInsurance,thefixedtypesofOAmareoften used tobalancethe costsof the technician.In this review, we searchedthroughfiveSRsontypesofOAm.Ahrensinvestigatedthe subjectivepatient-centeredoutcomes[5]andpolysomnographic indices[6].Theyconcludedthattheywereunabletodemonstrate themosteffectivetypeofOAthroughbothinvestigations. Serra-Torresetal.[14]concludedthatadjustableandcustom-madeOAms givebetterresultsthan fixedand prefabricatedappliances;and monoblocappliancescausemore adverseeffects. However,this conclusionwastheirinterpretationoftheincludedobservational studies.SivaramakrishnanandSridharan[21]comparedthe titrat-able OAmwiththe fixednon-titratable OAm.He includedfive studies.Fourofthefivestudieswereobservational,andonewas ashort-termcross-overrandomizedtrial.Therewasahighdegree ofheterogeneitybetweenthestudyresults,sotheydidnotconduct ameta-analysis.Therefore,theyconcludedthat“ThisSRdoesnot demonstratesignificantadvantagesinusingtitratableappliances”. Thisfieldhasmanyunresolvedquestions.Itisessentialto inves-tigateadherenceinadditiontoimprovementofOSAsymptoms, typifiedbytheAHI.Itisalsonecessarytoinvestigatethelong-term dentalandskeletalsideeffects.
OAmpositions the lower jaw anteriorly,thereby improving upperrespiratorytractobstruction.Bartoluccietal.[16] investi-gatedtheanteriorpositioningofthelowerjaw.TheyincludedRCT datatoanalyzetheratioofthemaximumpossibledistanceof ante-riormovementandimprovementrateofAHI,usingabubbleplot. TheyconcludedthattheimprovementintheAHIwasnot propor-tionaltotheincreaseinmandibularadvancement.Wealsofound thattheappropriatepositionofthelowerjawisnotuniform,and itdiffersdependingupontheindividual.However,inJapan,where thefixedOAm(non-titratable,butadjustableOAm)ismainstream, itisworthwhiletoprovidedentistswithanindicationoftheinitial positionofthemandible.
2.4. EffectofOAmandsideeffects
An important outcome of OSA treatment is prevention of complicationstypifiedbycardiovasculardisease,andreducingthe mortalityassociated with thesecomplications. This outcome is moreimportantforseverecasesofOSA.Mildcasesalsorequire cautionwithincreaseinthebaselineofAHIcausedbyagingand weightgain.TherearetwoSRsonimprovementofcardiovascular disease [8,23]. Iftikhar et al. [8] evaluated blood pressure, and concludedthat thepooledestimateshows a favorable effectof OAmonbloodpressure.However,healsostatedthatalmostall the data came from observational studies. Five years later, de Vriesetal.[23]evaluatedthecardiovasculareffects.AlltheRCTs hadafollow-upperiodofthreemonths,whichwasconsideredto betooshort.DeVriesetal.[23]alsocommentedthatonestudy [31]showedthatOAmwasaseffectiveasCPAPinreducingdeath fromacardiovascularcause,butthatstudywasnotanRCT,andit probablyhadselectionbias.Webelieveusingapropensityscore
andconductingalong-termobservationalstudywithacarefully designedOAmcouldresolvethisquestion.
TheSRbyHoekemaetal.[4]wasthefirstoneonOAm.They comparedOAmwithothertreatments,conductedameta-analysis onevaluationofthetypeofdevice,andalsoevaluatedsideeffects. Afterthat,therewerenoSRspublishedonsideeffectsforsome time.Patientscantoleratemanyshort-termsideeffects.However, thereareirreversiblesideeffectsamongthosethatoccuroverthe long-term.Therehasbeenanincreaseinthenumberofstudieswith longerstudyperiods.AnSRonlong-termsideeffectshasrecently beenpublished[26,28,29].Thereweredifferencesinthenumberof studiesincludedinthethreeSRs.ThereasonforthisisthatMartins etal.[28]includedRCTsonly.Thereweredifferencesinthe stud-iesincludedbyAraieetal.[26]andBartoluccietal.[29]because ofthesearchdate,andBartoluccietal.[29]onlytargetedstudies whereOAmwasusedfortwoormoreyears.Theinterpretationof thestudiesdifferedamongthethreeSRs.Forexample,thestudy byRingqvistetal.[32]wasincludedasanRCTbyMartinsetal. [28],andasanon-randomizedstudybyAraieetal.[26].However, itwasnotincludedatallbyBartoluccietal.[29].Eitherway, mor-phologicalchangesintheteethandskeletonwereseenoverthe long-term(Araieetal.[26]statedthattherewerenochangesin skeletalindicesormandibularrotation).Bartoluccietal.[29]used abubble plot,and concludedthatOAmtherapyproduces time-relateddentalandskeletalsideeffects.
Araieetal.[26],statedtheimportanceofcliniciansbeingaware ofthesideeffects.Wealsoemphasizeonthedutyofdentiststo explainthelong-termsideeffectstopatientsattheirinitialvisit totheclinic.Itisvitaltodealwiththesesideeffectsatanearly stage.One of the long-termside effects is posterior openbite. Reportsindicatethat70%ofthepatientsareunawareofthis symp-tom[33].Theextentofawarenessofmasticatorydisturbancesand cosmeticdisturbancescausedbydentalandskeletalsideeffects differsdependingonthepatient.Dentistsmustrespondtothese long-termsideeffectsonacase-by-casebasis.Regularpersistent follow-upmonitoringisimportant.AmongtheSRsincludedinthis study,noneinvestigatedlong-termadherence.Weconfirmedthis situationinourhospitalandalsoinvestigatedthesituationinthe studiesincludedintheSRs.Inparticular,weinvestigatedthe exam-inationsconductedbydentists,namelyfollow-upmonitoring.
3. Consultationrateforfollow-up:atourhospitalandin literature
3.1. Currentsituationinourhospital
Herewereportthecurrentsituationinourhospital(Ichikawa GeneralHospital,TokyoDentalCollege).Thedentistsinthis hospi-talhavebeentreatingpatientsdiagnosedwithOSAbythedivision ofotolaryngologyofthishospitaloranotherhospitalwithfixed OAmsince1999.Thepositionofthelowerjawwasadjusted refer-encingsubjectivesymptomsorsleeptests.Follow-upmonitoring wasstartedoncethepatientwasfreeofdiscomfort,andtheeffectof thedevicehasbeenconfirmedusingsleeptests.Thelongest dura-tionoffollow-upmonitoringwassetassixmonths.Themedical consultationsituationwascheckedeverytwomonths,andwe con-tactedpatientswhohaddiscontinuedconsultationsbytelephone. Patientswhohadnothadamedicalconsultationforoneyearor more,despiterepeatedtelephonecalls,wereconsideredtohave discontinuedtreatment(dropoutcase).
WesurveyedpatientswhohadreceivedOAmtherapyinthe one-yearperiod betweenJune 2015and May2016(in-hospital ethicsreviewnumber:I16–48).Theconsultationsituationofthe patientsduringthisperiodwascheckeduptoFebruary2019.There were46patientsintotal.Fivepatientswereunabletocontinueuse
duetoinabilitytogetusedtothedeviceorjawpain.Twopatients discontinuedtreatmentduetorelocation,andonepatientswitched toCPAP.OAmtherapywasstartedintheremaining38patients,but eightpatientsstoppedreportingforconsultationsbeforethesleep test.Approximately20%ofthepatientsrefusedtoundergothetest toconfirmtheeffect.Onepatientwasfoundnottohaveanyeffect fromthesleeptest.Finally,29patientshadtheeffectofthe treat-mentconfirmedwithasleeptest,andfollow-upmonitoringwas startedforthem.Sevenofthesepatientsdiscontinued consulta-tions.Duringtheapproximatethreeyearsoffollow-upmonitoring, oneinfourpatientsdiscontinuedconsultations.Somepatientswho discontinuedconsultationsarestillusingOAm.Hence,thisvalueis thepercentageofpatientswhocontinuedconsultation,andnotthe percentageofthosewhocontinuedtouseOAm.
3.2. Consultationrateintheliterature
WeusedthestudiesincludedintheSRsthatinvestigated long-termsideeffects[26,28,29].Doffetal.conductedanRCTcomparing OAmwithCPAP,andreportedtheresultsinmultiplearticles.We checked theFlow diagram by Doff et al. [34]. Sevenof the 51 patientswhoswitchedtoCPAPpartwaythroughthestudy;hence, 44 patientsweretreated withOAm. Twopatientswerelost to follow-up in thefirsttwo months,and one patientwaslost to follow-upbytheendofthestudy,twoyearslater.Thisgoodresult achievedintheirstudydemonstratesabiasofthecases participat-ingintheRCT.Weexaminedtheprospectiveobservationalstudies includedbyAraieetal.[26] andBartoluccietal.[29].Fransson etal.[35]reportedthat12outof77patients(15.6%) discontin-uedtreatmentoftheirownaccordduringthetwo-yearobservation period.Houetal.[36]reportedthat27outof151patients(17.9%) failedtoattendfollow-upappointmentsinthethree-year observa-tionperiod.Martínez-Gomisetal.[37]reportedthatnineoutof40 patients(22.5%)discontinuedtreatmentoftheirownaccordduring thefive-yearobservationperiod.Sharplesetal.[38]summarizedan investigativereportonclinicaleffectivenessandcost-effectiveness. Thiswasoneofthearticlesexcludedfromthisreview.They intro-ducedaFrenchcohortwitha76%usagerate(notconsultationrate) over2.75years[39].
Theaforementioneddataarefromthefacilitiesthatconducted theresearch.Weestimatethat20–25%ofpatientsstopcoming forconsultations(includingpatientsstillusingthedevice)when OAmtherapyiscontinuedforapproximatelythreeyearsinthese facilities.
4. Conclusions
4.1. Summarytodate
• CPAPissuperiortoOAinimprovingOSAsymptoms.
• ItisnecessarytosurveytheadherencetoOAmtherapyofpatients whostoppedCPAPtherapy.
• ThereislittleevidencesupportingthetheorythatOAmtherapy preventscardiovasculardiseaseorimproveslifeprognosis. • OAmtherapyhasdentalandskeletalsideeffectswithlong-term
use.
• ThereisstillroomtoinvestigatethetypesofOAm.Itis partic-ularlyessentialtoinvestigateadherenceandsideeffects after startingfollow-upmonitoring(oncetheeffectofOAmhasbeen confirmed).
36 K.Sato,T.Nakajima/JapaneseDentalScienceReview56(2020)32–37
4.2. Expectationsfromclinic-baseddentistsinvolvedinOAm therapy
Theclearresultsare:superiorityofCPAPanddentalandskeletal sideeffectsofOAm.Thelatterisespeciallyimportantfordentists. Long-termfollow-upmonitoringbydentistsisimportanttodeal withthissideeffectsofOAmandworseningoftheOSAbaseline. Thisreviewhasreiteratedtheimportancenotonlyoflong-term useofthedevicebypatients,butalsotheimportanceofreporting forconsultationsatamedicalinstitution,andbeingexaminedby dentists.However,thereareacertainnumberofpatientswho hesi-tatetovisitgeneralhospitalsordentalhospitals.Oneofthereasons forthisisthatalargenumberofthepatientsaremiddle-agedmen whoworkduringtheday.Clinicsareeasiertoattendthanhospitals. WebelievethatprovidingOAmtherapyinacliniccouldimprove thecontinuingconsultationrate.OAmrequiresadjustmentwhen patientsaretreatedwithdentalprosthetics.Fromthisperspective, thereareadvantagesintheclinic-baseddentiststreatingpatients withOAm.Themaintenanceintervalforperiodontitisisalsothe idealinterval forfollow-upmonitoringofOAtherapy.Although thepurposeofthisreviewwastoprovidethecurrentevidenceof OAmforclinic-baseddentists,thisreviewalsoprovesthebenefit ofdentalclinic-basedOAmtherapy.
Ontheotherhand,theAmericanAcademyofSleepMedicine andtheAmericanAcademyofDentalSleepMedicinecreateda clin-icalpracticeguidelinein2015[40].Thisclinicalpracticeguideline recommendsthatfollow-upmonitoringistobecontinued appro-priatelybysleepphysiciansandqualifieddentists.Itisimportant tofosterdentistswhoareabletodealwithsleepmedicine,which includesconductingmedicalexaminationsincollaborationwith sleep physicians. Enhancing under-graduate and post-graduate educationonsleepmedicine,andestablishingaspecialistsystem arestrategiesforfosteringtheabilityofdentiststohandleOAm therapyindentalclinics.Ontheotherhand,OAmplacesaburden ontheteethandthejaws.Searchingforanalternativetherapyis thedutyofdentists.Weanticipatethatincreasingthenumberof dentistsinvolvedinsleepmedicinewillresultinthecreationof newideasforanalternativetherapy.
Conflictsofinterestandsourceoffunding
Therearenoconflictsof interesttodeclare.No fundingwas acquiredforthisstudy.
Acknowledgments
Wewouldliketothanktheclinicalfellowsandstaffdoctorsof theDepartmentofOralMedicine,OralandMaxillofacialSurgery, TokyoDentalCollege,whohavetreatedthepatientswithOSAusing OAm.
References
[1]LimJ,LassersonTJ,FleethamJ,WrightJ.Oralappliancesforobstructivesleep apnoea.CochraneDatabaseSystRev2006;(1).CD004435.
[2]ZhuY, LongH,JianF,LinJ,ZhuJ,GaoM,etal.Theeffectivenessoforal appliancesforobstructivesleepapneasyndrome:ameta-analysis.JDent 2015;43(12):1394–402.
[3]LiuT,LiW,ZhouH,WangZ.Verifyingtherelativeefficacybetween continu-ouspositiveairwaypressuretherapyanditsalternativesforobstructivesleep apnea:anetworkmeta-analysis.FrontNeurol2017;8:289,http://dx.doi.org/ 10.3389/fneur.2017.00289.
[4]HoekemaA,StegengaB,DeBontLG.Efficacyandco-morbidityoforal appli-ancesinthetreatmentofobstructivesleepapnea-hypopnea:asystematic review.CritRevOralBiolMed2004;15(3):137–55.
[5]AhrensA,McGrathC,HäggU.Subjectiveefficacyoforalappliancedesign fea-turesinthemanagementofobstructivesleepapnea:asystematicreview.Am JOrthodDentofacialOrthop2010;138(5):559–76.
[6]AhrensA,McGrathC,HäggU.Asystematicreviewoftheefficacyoforal appli-ancedesigninthemanagementofobstructivesleepapnoea.EurJOrthod 2011;33(3):318–24.
[7]AlsufyaniNA, Al-SalehMA,MajorPW. CBCTassessment ofupperairway changesandtreatmentoutcomesofobstructivesleepapnoea:asystematic review.SleepBreath2013;17(3):911–23.
[8]IftikharIH,HaysER,IversonMA,MagalangUJ,MaasAK.Effectoforalappliances onbloodpressureinobstructivesleepapnea:asystematicreviewand meta-analysis.JClinSleepMed2013;9(2):165–74.
[9]OkunoK,SatoK,ArisakaT,HosohamaK,GotohM,TagaH,etal.Theeffectoforal appliancesthatadvancedthemandibleforwardandlimitedmouthopeningin patientswithobstructivesleepapnea:asystematicreviewandmeta-analysis ofrandomisedcontrolledtrials.JOralRehabil2014;41(7):542–54.
[10]Guarda-NardiniL,ManfrediniD,MionM,HeirG,Marchese-RagonaR. Anatom-icallybasedoutcomepredictorsoftreatmentforobstructivesleepapneawith intraoralsplintdevices:asystematicreviewofcephalometricstudies.JClin SleepMed2015;11(11):1327–34.
[11]SafferF,LubiancaNetoJF,RösingC,DiasC,ClossL.Predictorsofsuccessin thetreatmentofobstructivesleepapneasyndromewithmandibular reposi-tioningappliance:asystematicreview.IntArchOtorhinolaryngol2015;19(1): 80–5.
[12]BrattonDJ,GaislT,SchlatzerC,KohlerM.Comparisonoftheeffectsof con-tinuouspositiveairwaypressureandmandibularadvancementdeviceson sleepinessinpatientswithobstructivesleepapnoea:anetworkmeta-analysis. LancetRespirMed2015;3(11):869–78.
[13]SharplesLD,Clutterbuck-JamesAL,GloverMJ,BennettMS,ChadwickR,Pittman MA,etal.Meta-analysisofrandomisedcontrolledtrialsoforalmandibular advancementdevicesandcontinuouspositiveairwaypressureforobstructive sleepapnoea-hypopnoea.SleepMedRev2016;27:108–24.
[14]Serra-TorresS,Bellot-ArcisC,Montiel-CompanyJM,Marco-AlgarraJ, Almerich-Silla JM.Effectivenessof mandibularadvancement appliancesintreating obstructive sleep apnea syndrome: a systematic review. Laryngoscope 2016;126(2):507–14.
[15]OkunoK,PliskaBT,HamodaM,LoweAA,AlmeidaFR.Predictionoforal appli-ancetreatmentoutcomesinobstructivesleepapnea:asystematicreview.Sleep MedRev2016;30:25–33.
[16]Bartolucci ML,Bortolotti F,RaffaelliE,D’Anto V,MichelottiA,Alessandri BonettiG.Theeffectivenessofdifferentmandibularadvancementamountsin OSApatients:asystematicreviewandmeta-regressionanalysis.SleepBreath 2016;20(3):911–9.
[17]KastoerC,DieltjensM,OortsE,HamansE,BraemMJ,VandeHeyningPH,etal. Theuseofremotelycontrolledmandibularpositionerasapredictivescreening toolformandibularadvancementdevicetherapyinpatientswith obstruc-tivesleepapneathroughsingle-nightprogressivetitrationofthemandible: asystematicreview.JClinSleepMed2016;12(10):1411–21.
[18]Kuhn E,SchwarzEI,Bratton DJ,RossiVA,Kohler M.EffectsofCPAPand mandibularadvancementdevicesonhealth-relatedqualityoflifeinOSA:a systematicreviewandmeta-analysis.Chest2017;151(4):786–94.
[19]IftikharIH,BittencourtL,YoungstedtSD,AyasN,CistulliP,SchwabR,etal. ComparativeefficacyofCPAP,MADs,exercise-training,anddietaryweightloss forsleepapnea:anetworkmeta-analysis.SleepMed2017;30:7–14.
[20]CammarotoG,GallettiC,GallettiF,GallettiB,GallettiC,Gay-EscodaC. Mandibu-laradvancementdevicesvsnasal-continuouspositiveairwaypressureinthe treatmentofobstructivesleepapnoea.Systematicreviewandmeta-analysis. MedOralPatolOralCirBucal2017;22(4):e417–24.
[21]SivaramakrishnanG,SridharanK.Asystematicreviewontheeffectiveness oftitratableovernontitratablemandibularadvancementappliancesforsleep apnea.JIndianProsthodontSoc2017;17(4):319–24.
[22]Schwartz M, Acosta L, Hung YL, Padilla M, Enciso R. Effects of CPAP and mandibular advancement device treatment in obstructive sleep apnea patients: a systematic review and meta-analysis. Sleep Breath 2018;22(3):555–68.
[23]deVriesGE,WijkstraPJ,HouwerzijlEJ,KerstjensHAM,HoekemaA. Cardiovas-culareffectsoforalappliancetherapyinobstructivesleepapnea:asystematic reviewandmeta-analysis.SleepMedRev2018;40:55–68.
[24]GaoYN,WuYC,LinSY,ChangJZ,TuYK.Short-termefficacyofminimally inva-sivetreatmentsforadultobstructivesleepapnea:asystematicreviewand networkmeta-analysisofrandomizedcontrolledtrials.JFormosMedAssoc 2019;118(4):750–65.
[25]ChenH,AarabG,deLangeJ,vanderSteltP,LobbezooF.Theeffectsof noncon-tinuouspositiveairwaypressuretherapiesontheaerodynamiccharacteristics oftheupperairwayofobstructivesleepapneapatients:asystematicreview.J OralMaxillofacSurg2018;76(7):1559e1–e11.
[26]AraieT,OkunoK,OnoMinagiH,SakaiT.Dentalandskeletalchangesassociated withlong-termoralapplianceuseforobstructivesleepapnea:asystematic reviewandmeta-analysis.SleepMedRev2018;41:161–72.
[27]Zhang M,Liu Y, Liu Y, YuF, Yan S,Chen L, et al. Effectivenessoforal appliancesversuscontinuouspositiveairwaypressureintreatmentofOSA patients:anupdatedmeta-analysis.Cranio2018:1–18,http://dx.doi.org/10. 1080/08869634.2018.1475278.
[28]MartinsOFM,ChavesJuniorCM,RossiRRP,CunaliPA,Dal-FabbroC,Bittencourt L.Sideeffectsofmandibularadvancementsplintsforthetreatmentof snor-ingandobstructivesleepapnea:asystematicreview.DentalPressJOrthod 2018;23(4):45–54.
[29]BartolucciML,BortolottiF,MartinaS,CorazzaG,MichelottiA, Alessandri-Bonetti G. Dental and skeletal long-term side effects of mandibular
advancementdevicesinobstructivesleepapneapatients:asystematicreview withmeta-regressionanalysis.EurJOrthod2019;41(1):89–100.
[30]Al-JewairTS,GaffarBO,Flores-MirC.Qualityassessmentofsystematicreviews on the efficacyof oral appliance therapyfor adult and pediatric sleep-disorderedbreathing.JClinSleepMed2016;12(8):1175–83.
[31]AnandamA,PatilM,AkinnusiM,JaoudeP,El-SolhAA.Cardiovascularmortality inobstructivesleepapnoeatreatedwithcontinuouspositiveairwaypressure ororalappliance:anobservationalstudy.Respirology2013;18(8):1184–90.
[32]RingqvistM,Walker-EngströmML,TegelbergA,RingqvistI.Dentalandskeletal changesafter4yearsofobstructivesleepapneatreatmentwithamandibular advancementdevice:aprospective,randomizedstudy.AmJOrthod Dentofa-cialOrthop2003;124(1):53–60.
[33]PerezCV,deLeeuwR,OkesonJP,CarlsonCR,LiHF,BushHM,etal.The inci-denceandprevalenceoftemporomandibulardisordersandposterioropenbite inpatientsreceivingmandibularadvancementdevicetherapyforobstructive sleepapnea.SleepBreath2013;17(March(1)):323–32.
[34]Doff MH,HoekemaA,WijkstraPJ,vanderHoevenJH,HuddlestonSlater JJ, de Bont LG, et al. Oral appliance versus continuous positive airway pressure inobstructivesleepapneasyndrome:a2-yearfollow-up. Sleep 2013;36(9):1289–96.
[35]FranssonAM,TegelbergA,JohanssonA,WennebergB.Influenceonthe mas-ticatorysystemintreatmentofobstructivesleepapneaandsnoringwitha
mandibularprotrudingdevice:a2-yearfollow-up.AmJOrthodDentofacial Orthop2004;126(6):687–93.
[36]HouHM,SamK,HäggU,RabieAB,BendeusM,YamLY,etal.Long-term dento-facialchangesinChineseobstructivesleepapneapatientsaftertreatmentwith amandibularadvancementdevice.AngleOrthod2006;76(3):432–40.
[37]Martinez-GomisJ,WillaertE,NoguesL,PascualM,SomozaM,MonasterioC. Fiveyearsofsleepapneatreatmentwithamandibularadvancementdevice. Sideeffectsandtechnicalcomplications.AngleOrthod2010;80(1):30–6.
[38]SharplesL,GloverM,Clutterbuck-JamesA,BennettM,JordanJ,ChadwickR, etal.Clinicaleffectivenessandcost-effectivenessresultsfromtherandomised controlledTrialofOralMandibularAdvancement DevicesforObstructive sleepapnoea-hypopnoea (TOMADO) andlong-term economic analysisof oraldevicesandcontinuouspositiveairwaypressure.HealthTechnolAssess 2014;18(67):1–296.
[39]BretteC,RamanantsoaH,RenouardiereJ,RenouardiereR,RoismanG,Escourrou P.Amandibularadvancementdeviceforthetreatmentofobstructivesleep apnea:long-termuseandtolerance.IntOrthod2012;10(4):363–76.
[40]RamarK,DortLC,KatzSG,LettieriCJ,HarrodCG,ThomasSM,etal.Clinical prac-ticeguidelineforthetreatmentofobstructivesleepapneaandsnoringwithoral appliancetherapy:anupdatefor2015.JClinSleepMed2015;11(7):773–827.